Psyence Group Inc. (PSYGF)

USD 0.03

(258.67%)

Inventory Summary of Psyence Group Inc.

  • Psyence Group Inc.'s latest annual inventory in 2024 was - CAD , down -100.0% from previous year.
  • Psyence Group Inc.'s latest quarterly inventory in 2024 FY was - CAD , down -100.0% from previous quarter.
  • Psyence Group Inc. reported annual inventory of 40 Thousand CAD in 2023, down 0.0% from previous year.
  • Psyence Group Inc. reported annual inventory of 40 Thousand CAD in 2022, up 120.42% from previous year.
  • Psyence Group Inc. reported quarterly inventory of - CAD for 2024 Q4, down -100.0% from previous quarter.
  • Psyence Group Inc. reported quarterly inventory of - CAD for 2024 Q1, down -100.0% from previous quarter.

Annual Inventory Chart of Psyence Group Inc. (2024 - 2016)

Historical Annual Inventory of Psyence Group Inc. (2024 - 2016)

Year Inventory Inventory Growth
2024 - CAD -100.0%
2023 40 Thousand CAD 0.0%
2022 40 Thousand CAD 120.42%
2021 -195.9 Thousand CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%

Peer Inventory Comparison of Psyence Group Inc.

Name Inventory Inventory Difference
AstraZeneca PLC 5.41 Billion USD 100.0%
Bristol-Myers Squibb Company PFD CONV 2 2.66 Billion USD 100.0%
CSPC Pharmaceutical Group Limited 442.43 Million USD 100.0%
Clarus Therapeutics Holdings, Inc. 14.21 Million USD 100.0%
Novartis AG 5.91 Billion USD 100.0%
PT Kalbe Farma Tbk. 451.27 Million USD 100.0%